We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Premature Coronary Atherosclerosis in Scleroderma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00372398
First Posted: September 6, 2006
Last Update Posted: September 16, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Tuen Mun Hospital
  Purpose
The purpose of this trial is to study the proportion of scleroderma patients who suffer from asymptomatic coronary atherosclerosis compared to healthy controls.

Condition
Scleroderma

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Premature Coronary Atherosclerosis in Scleroderma: A Case Control Study

Resource links provided by NLM:


Further study details as provided by Tuen Mun Hospital:

Enrollment: 28
Study Start Date: October 2006
Study Completion Date: July 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Detailed Description:
Coronary calcium scores will be obtained from a group of patients with scleroderma and a group of controls. Comparison of the calcium scores will be made.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
scleroderma patients
Criteria

Inclusion Criteria:

  1. Age >= 18 years.
  2. Fulfillment of the American College of Rheumatology (ACR) criteria for the classification of scleroderma.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00372398


Locations
Hong Kong
Tuen Mun Hospital
Hong Kong, Hong Kong
Sponsors and Collaborators
Tuen Mun Hospital
Investigators
Principal Investigator: CC Mok, MD FRCP Tuen Mun Hospital, Hong Kong
  More Information

Responsible Party: CC Mok, Tuen Mun Hospital, Hong Kong
ClinicalTrials.gov Identifier: NCT00372398     History of Changes
Other Study ID Numbers: NTWC/CREC/429/06
First Submitted: September 5, 2006
First Posted: September 6, 2006
Last Update Posted: September 16, 2010
Last Verified: September 2010

Keywords provided by Tuen Mun Hospital:
scleroderma
sclerosis
atherosclerosis

Additional relevant MeSH terms:
Atherosclerosis
Scleroderma, Systemic
Scleroderma, Diffuse
Scleroderma, Localized
Coronary Artery Disease
Myocardial Ischemia
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases
Connective Tissue Diseases
Skin Diseases
Coronary Disease
Heart Diseases